Publications

Found 23 results
Sort by: Author Title [ Type (Desc)] Year
Filters: First Letter Of Last Name is N  [Clear All Filters]
Journal Article
Amtmann D, Bamer AM, Cook KF, Askew RL, Noonan VK, Brockway J A. "University of Washington Self-Efficacy Scale: A New Self-Efficacy Scale for People With Disabilities." Archives of Physical Medicine and Rehabilitation. 2012.
Nash RA, Kraft GH, Bowen JD, et al. "Treatment of Severe Multiple Sclerosis (MS) with High Dose Immunosuppressive Therapy (HDIT) and Autologous Stem Cell Transplantation (SCT)." Multiple Sclerosis. 2000;6(6):414.
Cui J Y, Kraft GH, Bowen JD, McSweeney PA, Georges GE, Nash RA. "Stem Cell Transplantation in Multiple Sclerosis." Journal of Spinal Cord Medicine. 2002;25(3):235.
Kraft GH, Bowen JD, Sullivan KM, et al. "Severe Multiple Sclerosis (MS) May Be Controlled with High Dose Immunosuppressive Therapy (HDIT) and Autologous Stem Cell Transplantation (SCT)." International Journal of MS Care. 2001;3(2):24.
Schwid SR, Petrie MD, Murray R, et al. "A randomized controlled study of the acute and chronic effects of cooling therapy for MS." Neurology. 2003;60(12):1955-60.
Wundes A, Kraft GH, Bowen JD, et al. "Poor-prognosis relapsing-remitting patient treated by autologous hematopoietic stem-cell transplantation: 1 year follow-up." International Journal of MS Care. 2008;10(S1):54-55.
Wundes A, Kraft GH, Bowen JD, Gooley TA, Nash RA. "Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting." Clin Neurol Neurosurg. 2010;112(10):876-82.
Wundes A, Kraft GH, Bowen JD, Gooley TA, Nash RA. "Mitoxantrone for worsening MS: compliance problems in clinical practice." International Journal of MS Care. 2007;9(2):82.

Pages

Sign up!

We'll send you a regular email newsletter keeping you informed of what's happening at the MSRRTC.

Send us a message to sign-up. 

Studies Seeking Volunteers:

Currently there are no MSRRTC studies seeking volunteers.

Please check the Dept. of Rehabilitation Medicine's website for other studies on Multiple Sclerosis.